HYPR RSI Chart
Last 7 days
12.7%
Last 30 days
-2.2%
Last 90 days
-19.8%
Trailing 12 Months
-31.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 11.7M | 0 | 0 | 0 |
2023 | 7.9M | 9.8M | 9.8M | 11.0M |
2022 | 2.7M | 3.8M | 5.8M | 6.8M |
2021 | 594.5K | 895.0K | 1.2M | 1.5M |
2020 | 0 | 0 | 0 | 294.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 16, 2024 | teisseyre thomas | sold | -3,585 | 1.11 | -3,230 | chief operating officer |
Nov 16, 2023 | teisseyre thomas | sold | -3,345 | 1.26 | -2,655 | chief operating officer |
Aug 16, 2023 | teisseyre thomas | sold | -6,294 | 2.26 | -2,785 | chief operating officer |
Aug 16, 2023 | siddiqui khan | sold | -3,907 | 2.26 | -1,729 | cmo and chief strategy officer |
May 16, 2023 | siddiqui khan | sold | -2,168 | 1.25 | -1,735 | cmo and chief strategy officer |
Feb 16, 2023 | gupta alok | sold | -7,802 | 1.39 | -5,613 | chief financial officer |
Feb 16, 2023 | siddiqui khan | sold | -6,442 | 1.39 | -4,635 | cmo and chief strategy officer |
Dec 16, 2022 | hc sponsor llc | sold | - | - | -5,534,000 | - |
Dec 14, 2022 | sainz maria | bought | 4,750 | 0.95 | 5,000 | president and ceo |
Dec 09, 2022 | sainz maria | acquired | 10,561 | 0.85 | 12,425 | president and ceo |
Which funds bought or sold HYPR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -31.15 | -9,198 | 14,677 | -% |
May 15, 2024 | BARCLAYS PLC | new | - | 45,000 | 45,000 | -% |
May 15, 2024 | Cresset Asset Management, LLC | unchanged | - | -1,380 | 11,500 | -% |
May 15, 2024 | Squarepoint Ops LLC | reduced | -16.34 | -9,705 | 28,648 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 12.48 | 58.00 | 13,570 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | sold off | -100 | -11,760 | - | -% |
May 15, 2024 | Alyeska Investment Group, L.P. | unchanged | - | -45,000 | 375,000 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -25.45 | -8,542 | 17,004 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | reduced | -30.41 | -46,389 | 76,119 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | -20,592 | 171,600 | -% |
Unveiling Hyperfine, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Hyperfine, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Hyperfine, Inc. News
Income Statement (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Revenue | 22.7% | 3,295,000 | 2,686,000 | 2,330,000 | 3,381,000 | 2,635,000 | 1,424,000 | 2,348,000 | 1,533,000 | 1,509,000 | 436,000 | 371,000 | 358,000 | 331,000 | - |
Gross Profit | 30.9% | 1,354,000 | 1,034,000 | 1,124,000 | 1,444,000 | 1,155,000 | 300,000 | 688,000 | -165,000 | 84,000 | -453,000 | -338,000 | -99,000 | -277,000 | - |
Operating Expenses | -5.2% | 12,004,000 | 12,663,000 | 12,883,000 | 13,136,000 | 14,190,000 | 13,929,000 | 13,970,000 | 23,027,000 | 23,855,000 | 25,634,000 | 16,052,000 | 14,487,000 | 7,528,000 | - |
S&GA Expenses | -20.7% | 2,004,000 | 2,528,000 | 2,529,000 | 2,499,000 | 2,547,000 | 2,874,000 | 3,434,000 | 3,750,000 | 4,161,000 | 4,592,000 | 2,787,000 | 1,787,000 | 1,196,000 | - |
R&D Expenses | -6.6% | 5,570,000 | 5,962,000 | 5,739,000 | 5,331,000 | 5,461,000 | 5,219,000 | 7,338,000 | 7,265,000 | 8,334,000 | 8,893,000 | 6,438,000 | 6,037,000 | 4,474,000 | - |
EBITDA Margin | 10.7% | -3.50 | -3.91 | -4.66 | -4.91 | -7.62 | -10.59 | -14.61 | -22.96 | -29.90 | -42.86 | -19.35 | -25.85 | -38.92 | -78.70 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 7.8% | -9,848,000 | -10,684,000 | -10,757,000 | -10,637,000 | -12,160,000 | -13,059,000 | -13,171,000 | -23,159,000 | -23,775,000 | -26,085,000 | -16,392,000 | -14,580,000 | -7,794,000 | - |
EBT Margin | 10.6% | -3.59 | -4.01 | -4.77 | -5.01 | -7.75 | -10.74 | -14.79 | -23.23 | -30.23 | -43.35 | -19.60 | -26.18 | -39.41 | -79.68 |
Net Income | 7.8% | -9,848,000 | -10,684,000 | -10,757,000 | -10,637,000 | -12,160,000 | -13,059,000 | -13,171,000 | -23,159,000 | -23,775,000 | -26,085,000 | -16,392,000 | -14,580,000 | -7,794,000 | - |
Net Income Margin | 10.6% | -3.59 | -4.01 | -4.77 | -5.01 | -7.75 | -10.74 | -14.79 | -23.23 | -30.23 | -43.35 | -19.60 | -26.18 | -39.41 | -79.68 |
Free Cashflow | -24.1% | -12,655,000 | -10,196,000 | -8,984,000 | -9,881,000 | -13,552,000 | -15,503,000 | -12,967,000 | -16,857,000 | -27,597,000 | -19,110,000 | -11,004,000 | -12,123,000 | -7,656,000 | - |
Balance Sheet | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | -9.3% | 85.00 | 94.00 | 103 | 113 | 122 | 134 | 148 | 162 | 179 | 202 | 81.00 | 208 | 208 | 72.00 | 31.00 |
Current Assets | -10.4% | 80.00 | 89.00 | 98.00 | 108 | 117 | 129 | 144 | 157 | 174 | 197 | 76.00 | 1.00 | 1.00 | 68.00 | 28.00 |
Cash Equivalents | -15.9% | 63.00 | 75.00 | 85.00 | 94.00 | 104 | 117 | 132 | 145 | 162 | 191 | 65.00 | 77.00 | 86.00 | 64.00 | 26.00 |
Inventory | 10.9% | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 | 3.00 | - | - | 2.00 | - |
Net PPE | 23.6% | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | - | - | 2.00 | 0.00 |
Liabilities | 0.1% | 10.00 | 10.00 | 9.00 | 9.00 | 9.00 | 10.00 | 13.00 | 11.00 | 12.00 | 16.00 | 14.00 | 9.00 | 7.00 | 4.00 | - |
Current Liabilities | 0.0% | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 | 9.00 | 12.00 | 10.00 | 11.00 | 16.00 | 14.00 | 1.00 | 0.00 | 4.00 | 2.00 |
Shareholder's Equity | -10.4% | 76.00 | 84.00 | 94.00 | 103 | 113 | 124 | 135 | 151 | 167 | 186 | - | 5.00 | 5.00 | 0.00 | - |
Retained Earnings | -3.9% | -263 | -253 | -243 | -232 | -221 | -209 | -196 | -183 | -160 | -136 | -110 | -7.35 | -5.92 | -71.47 | -48.04 |
Additional Paid-In Capital | 0.3% | 339 | 338 | 337 | 336 | 334 | 333 | 331 | 334 | 327 | 323 | 9.00 | - | - | 10.00 | 8.00 |
Shares Outstanding | 0.9% | 72.00 | 71.00 | 71.00 | 71.00 | 71.00 | 70.00 | 70.00 | 70.00 | 70.00 | 4.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 |
Float | - | - | - | - | 116 | - | - | - | 121 | - | - | - | 204 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2019Q4 |
Cashflow From Operations | -25.9% | -12,510 | -9,938 | -8,721 | -9,659 | -13,491 | -15,345 | -12,794 | -16,911 | -27,289 | -18,135 | -9,943 | -11,618 | -7,486 | - | - | - |
Share Based Compensation | -19.9% | 1,032 | 1,288 | 1,194 | 1,133 | 1,126 | 1,793 | -2,354 | 7,102 | 4,111 | 3,770 | 1,375 | 1,489 | 267 | - | - | - |
Cashflow From Investing | 43.8% | -145 | -258 | -263 | -222 | -61.00 | -158 | -173 | 54.00 | -308 | -975 | -1,061 | -505 | -170 | - | - | - |
Cashflow From Financing | 96.4% | 55.00 | 28.00 | 39.00 | 58.00 | 49.00 | 5.00 | - | - | - | 141,328 | 1,264 | 2,965 | 31,210 | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Sales | ||
Total sales | $ 3,295 | $ 2,635 |
Cost of sales | ||
Total cost of sales | 1,941 | 1,480 |
Gross margin | 1,354 | 1,155 |
Operating Expenses: | ||
Research and development | 5,570 | 5,461 |
General and administrative | 4,430 | 6,182 |
Sales and marketing | 2,004 | 2,547 |
Total operating expenses | 12,004 | 14,190 |
Loss from operations | (10,650) | (13,035) |
Interest income | 796 | 869 |
Other income, net | 6 | 6 |
Loss before provision for income taxes | (9,848) | (12,160) |
Provision for income taxes | 0 | 0 |
Net loss and comprehensive loss | $ (9,848) | $ (12,160) |
Earnings Per Share, Basic | $ (0.14) | $ (0.17) |
Earnings Per Share, Diluted | $ (0.14) | $ (0.17) |
Denominator for Basic EPS - Weighted-average common stock | 71,934,045 | 70,864,226 |
Denominator for Dilutive EPS - Weighted-average common stock | 71,934,045 | 70,864,226 |
Device | ||
Sales | ||
Total sales | $ 2,704 | $ 2,132 |
Cost of sales | ||
Total cost of sales | 1,499 | 1,071 |
Service | ||
Sales | ||
Total sales | 591 | 503 |
Cost of sales | ||
Total cost of sales | $ 442 | $ 409 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|---|---|
CURRENT ASSETS: | ||||
Cash and cash equivalents | $ 63,204 | $ 75,183 | ||
Restricted cash | 621 | |||
Accounts receivable, less allowance of $248 and $321 as of March 31, 2024 and December 31, 2023, respectively | 5,343 | 3,189 | ||
Unbilled receivables | 895 | 942 | ||
Inventory | 7,298 | 6,582 | ||
Prepaid expenses and other current assets | 2,950 | 2,391 | ||
Total current assets | 79,690 | 88,908 | ||
Property and equipment, net | 3,706 | 2,999 | ||
Other long term assets | 2,047 | 2,292 | ||
Total assets | 85,443 | 94,199 | ||
CURRENT LIABILITIES: | ||||
Accounts payable | 2,532 | 1,214 | ||
Deferred grant funding | 621 | |||
Deferred revenue | 1,527 | 1,453 | ||
Accrued expenses and other current liabilities | 4,663 | 5,419 | ||
Total current liabilities | 8,767 | 8,768 | ||
Long term deferred revenue | 1,021 | 968 | ||
Other noncurrent liabilities | 17 | 64 | ||
Total liabilities | 9,805 | 9,800 | ||
COMMITMENTS AND CONTINGENCIES (NOTE 13) | ||||
STOCKHOLDERS' EQUITY: | ||||
Additional paid-in capital | 339,201 | 338,114 | ||
Accumulated deficit | (263,570) | (253,722) | ||
Total stockholders' equity | 75,638 | 84,399 | $ 123,722 | |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 85,443 | 94,199 | ||
Class A Common Stock | ||||
STOCKHOLDERS' EQUITY: | ||||
Common stock | 5 | 5 | ||
Class B Common Stock | ||||
STOCKHOLDERS' EQUITY: | ||||
Common stock | 2 | 2 | ||
Related Party | ||||
CURRENT LIABILITIES: | ||||
Due to related parties | $ 45 | $ 61 |